Lanean...
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
Broadly neutralizing antibodies (bNAbs) against HIV-1 envelope (Env) inform vaccine design and are potential therapeutic agents. We identified SF12 and related bNAbs with up to 62% neutralization breadth from an HIV-infected donor. SF12 recognized a glycan-dominated epitope on Env’s silent face and...
Gorde:
| Argitaratua izan da: | Immunity |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Cell Press
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6591006/ https://ncbi.nlm.nih.gov/pubmed/31126879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2019.04.014 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|